ABSTRACT
Opponents of medical marijuana tend to focus on the "social issues" surrounding substance use. They argue that marijuana is addictive, serves as a gateway drug, has little medicinal value, and leads to criminal activity (Adams 2008; Blankstein 2010) . Another oftenraised argument against legalization is that it encourages the recreational use of marijuana, especially by teenagers (Brady et al. 2011; O'Keefe and Earleywine 2011) . Proponents contend that marijuana is both efficacious and safe, and can be used to treat the side effects of chemotherapy as well as the symptoms of AIDS, multiple sclerosis, epilepsy, glaucoma and other serious illnesses. They cite clinical research showing that marijuana relieves chronic pain, nausea, muscle spasms and appetite loss (Eddy 2010; Marmor 1998; Watson et al. 2000) , and note that neither the link between medical marijuana and youth consumption, nor the link between medical marijuana and criminal activity, has been substantiated (Belville 2011; Corry et al. 2009; Hoeffel 2011; Lamoureux 2011) . Thirteen states enacted a MML during this period. FARS includes the time of day the traffic fatality occurred, the day of the week it occurred, and whether alcohol was involved. Using this information, we contribute to the long-standing debate on whether marijuana and alcohol are substitutes or complements.
Specifically, we find that traffic fatalities fall by nearly 9 percent after the legalization of medical marijuana. However, the effect of MMLs on traffic fatalities involving alcohol appears to be larger, and is estimated with more precision, than the effect of MMLs on traffic fatalities that did not involve alcohol. Likewise, we find that the estimated effects of MMLs on fatalities at night and on weekends (when alcohol consumption rises) are larger, and are more precise, than the estimated effects of MMLs on fatalities during the day and on weekdays.
Finally, the relationship between MMLs and more direct measures of alcohol consumption is examined. Using data from the Behavioral Risk Factor Surveillance System 3 (BRFSS), we find that MMLs are associated with decreases in the number of drinks consumed, especially among 20-through 29-year-olds, providing additional evidence that alcohol is the mechanism by which traffic fatalities are reduced. Using data from the Beer Institute, we find that beer sales fall after a MML comes into effect, suggesting that marijuana substitutes for beer, the most popular alcoholic beverage among young adults.
BACKGROUND

A brief history of medical marijuana
Marijuana was introduced in the United States in the early-1600s by Jamestown settlers who used the plant in hemp production; hemp cultivation remained a prominent industry until the mid-1800s (Deitch 2003) . During the census of 1850, the United States recorded over 8,000
cannabis plantations of at least 2,000 acres (U.K. Cannabis Campaign 2011). Throughout this period, marijuana was commonly used by physicians and pharmacists to treat a broad spectrum of ailments (Pacula et al. 2002) . From 1850 to 1942, marijuana was included in the United States Pharmacopoeia, the official list of recognized medicinal drugs (Bilz 1992 ).
In 1913, California passed the first marijuana prohibition law aimed at recreational use (Gieringer 1999) ; by 1936, the remaining 47 states had followed suit (Eddy 2010) . In 1937, The Marihuana Tax Act effectively discontinued the use of marijuana for medicinal purposes (Bilz 1992) , and marijuana was classified as a Schedule I drug in 1970.
1 According to the Controlled Substances Act (CSA), a Schedule I drug must have a "high potential for abuse," and "no currently accepted medical use in treatment in the United States" (Eddy 2010 Laboratory studies have shown that cannabis use impairs driving-related functions such as distance perception, reaction time, and hand-eye coordination (Kelly et al. 2004; Sewell et al. 2009 ). However, neither simulator nor driving-course studies provide consistent evidence that these impairments to driving-related functions lead to an increased risk of collision (Kelly et al. 2004; Sewell et al. 2009 ). Drivers under the influence of marijuana reduce their velocity, avoid risky maneuvers, and increase their "following distances," suggesting compensatory behavior (Kelly et al. 2004; Sewell et al. 2009 ). In addition, there appears to be an important learning-bydoing component to driving under the influence of marijuana: experienced users show substantially less functional impairment than infrequent users (Sutton 1983 ).
Studies on substance use and driving
3 Federal regulations prohibit doctors from writing prescriptions for marijuana. In addition, even if a doctor were to illegally prescribe marijuana, it would be against federal law for pharmacies to distribute it. Doctors in states that have legalized medical marijuana avoid violating federal law by recommending marijuana to their patients rather than prescribing its use. Because it is illegal for pharmacies to distribute marijuana, cannabis products intended for medicinal use are typically obtained from cooperatives or dispensaries (Eddy 2010) .
4 Information on when MMLs were passed was obtained from a recent Congressional Research Services Report by Eddy (2010) . Prior to the Obama administration, federal agents raided medical marijuana distributors who violated federal laws even if they complied with state statutes. In 2009, Attorney General Holder stated that the administration would discontinue raids on medical marijuana dispensaries (Johnston and Lewis 2009) . Since 2009, the search and seizure rates have slowed; however, they have not ceased altogether (CNN 2011; Hamilton 2011; L.A. Now 2011) .
Like marijuana, alcohol impairs driving-related functions such as reaction time and handeye coordination (Kelly et al. 2004; Sewell et al. 2009 ). Moreover, there is unequivocal evidence from simulator and driving-course studies that alcohol consumption leads to an increased risk of collision (Kelly et al. 2004; Sewell et al. 2009 ). Even at low doses, drivers under the influence of alcohol tend to underestimate the degree to which they are impaired (MacDonald et al. 2008; Marczinski et al. 2008; Robbe and O'Hanlon 1993; Sewell et al. 2009 ), drive at faster speeds, and take more risks (Burian et al. 2002; Ronen et al. 2008; Sewell et al. 2009 ). When used in conjunction with marijuana, alcohol appears to have an "additive or even multiplicative" effect on driving-related functions (Sewell et al. 2009, p. 186) , although there is evidence that chronic marijuana users are less impaired by alcohol than infrequent users (Jones and Stone 1970; Marks and MacAvoy 1989; Wright and Terry 2002) .
5
A consensus has not been reached with regard to the relationship between marijuana and alcohol consumption. A number of studies have found evidence of complementarity between marijuana and alcohol (Pacula 1998; Farrelly et al. 1999; Williams et al. 2004 ; Yörük and Yörük
The relationship between marijuana and alcohol consumption
The results discussed in the previous section have different policy implications depending upon whether marijuana and alcohol are substitutes or complements. If they are complements, then MMLs could lead to more traffic fatalities as the consumption of marijuana and alcohol increase. If they are substitutes, then MMLs could lead to fewer traffic fatalities as alcohol consumption decreases.
5 A large body of research in epidemiology attempts to assess the effects of substance use based on observed THC and alcohol levels in the blood of drivers who have been in accidents. For marijuana, the results have been mixed. In contrast, these studies have consistently shown that the likelihood of an accident increases with BAC levels (Sewell et al. 2009 ). However, it should be noted that this research generally suffers from the problems inherent to non-random assignment.
6 2011). Others, however, lend support to the hypothesis that marijuana and alcohol are substitutes. For instance, Chaloupka and Laixuthai (1997) and Saffer and Chaloupka (1999) found that marijuana decriminalization led to decreased alcohol consumption, while DiNardo and Lemieux (2001) found that increases in the minimum legal drinking age were positively associated with the use of marijuana.
Two recent studies used a regression discontinuity approach to examine the effect of the minimum legal drinking age on marijuana use, but came to different conclusions. Crost and Guerrero (2011) concluded that alcohol and marijuana were substitutes, while Yörük and Yörük (2011) concluded that they were complements. However, according to Yörük and Yörük (2011) , approximately 75 percent of NLSY97 respondents between the ages of 19 and 22 smoked marijuana in the past month. This figure is inconsistent with evidence on marijuana use by young adults available from other studies. 6 Medical marijuana dispensaries are ubiquitous in some parts of Denver, Los Angeles, Seattle, and Detroit; in Colorado and Montana, more than two percent of the population is a registered medical marijuana patient. Compton et al. (2004) found that approximately 11 percent of 18-through 29 year-olds smoked marijuana in the past year; Pacula (1998) found that approximately 20 percent of respondents in the NLSY79 admitted to marijuana use in the past month; and DeSimone and Farrelly (2003) reported that approximately 16 percent of 18-through 29-year-old respondents in the National Household Surveys on Drug Abuse used marijuana in the past year. MMLs afford suppliers to the medicinal market some degree of protection against prosecution, and allow patients to buy medical marijuana without fear of being arrested or fined.
MEDICAL MARIJUNA LAWS AND MARIJUANA USE
Because it is prohibitively expensive for the government to ensure that all marijuana ostensibly grown for the medicinal market ends up in the hands of registered patients (especially in states that permit home cultivation), diversion to the illegal market likely occurs. 8 Moreover, the majority of MMLs allow patients to register based on medical conditions that cannot be objectively confirmed (e.g. chronic pain and nausea). 9 According to recent Arizona registry data, only 7 out of 11,186 applications for medical marijuana have been denied approval.
10
Although there are reasons to expect MMLs to increase the consumption of marijuana, the evidence has consisted primarily of popular press reports and anecdotes.
11
Funded by the
In an effort to fill this gap, we draw on data from the National Survey on Drug Use and Health (NSDUH) to examine marijuana use in three states that passed MMLs in the mid-2000s.
Substance Abuse and Mental Health Services Administration (an agency of the U.S. Department of Health and Human Services), the NSDUH is an annual, nationally
9 Chronic pain appears to be the most common medical condition among medical marijuana patients (see Appendix  Table 1 ). There is anecdotal evidence of "quick-in, quick-out mills," where physicians provide recommendations for a nominal fee (Cochran 2010; Sun 2010) .
10 It has been argued that MMLs increase recreational demand, especially among minors, through a destigmatization effect. Bachman et al. (1998) and Pacula et al. (2001) provide evidence that marijuana use increases when individuals view it as either socially acceptable or less harmful. Using state-level data for the period 1999-2008 from the National Survey on Drug Use and Health (NSDUH), de Silva and Torgler (2011) found that the passage of a MML was actually associated with an increased tendency to view marijuana use as risky. In addition, it is possible that MMLs encourage the recreational use of marijuana by increasing the probability of interacting with a person who uses it for medicinal purposes (Pacula et al. 2010 Marijuana use among Montana residents (ages 12 and over) increased by 1.7 percentage points from the pre-legalization to the post-legalization period. However, because marijuana use in neighboring states increased by 0.8 percentage points, the difference-in-differences estimate is 0.9 percentage points. Table 2 provides no evidence that Montana's MML encouraged minors to smoke marijuana. In contrast, Montana's MML is associated with a 3.3 percentage point increase in marijuana use among 18-through 25-year-olds (or a 19 percent increase from the pre-12 Our attempts at obtaining individual-level NSDUH data with state identifiers were politely rebuffed. Monitoring the Future and the Youth Risk Behavior Surveys are important sources of data for researchers interested in the determinants of marijuana use, but they do not contain information on adults.
13 If a neighboring state had already passed a MML, then it was not included in the control group.
14 Although the NSDUH does not provide individual-level data with state identifiers, they do provide the sample sizes upon which the state-level rates of substance use are based. We used these sample sizes and the weighted rates to calculate approximate standard errors.
legalization mean). The law is also associated with a 0.6 percentage point increase among older adults, but this estimate is not statistically significant.
The medical marijuana industry is thriving in Montana. There are currently more than 27,000 registered patients, representing almost 3 percent of the population. In contrast, Rhode
Island legalized medical marijuana on June 3, 2006, and five years later there were approximately 3,000 registered patients; Vermont legalized medical marijuana on July 1, 2004, and more than six years later there were only 349 registered patients. 
MEDICAL MARIJUNA LAWS AND TRAFFIC FATALITIES
Data on traffic fatalities
As noted above, we use data from Fatal Accident Report System (FARS) for the period State-level traffic fatality rates were calculated by sex and age using population data from the National Cancer Institute.
Fortunately, the inclusion of state fixed effects eliminates the influence of time-invariant differences in data collection and reporting. Focusing on nighttime and weekend fatal crashes can provide additional insight into the role of alcohol and help address the measurement error issue. As noted by Dee (1999) , a substantial proportion of fatal crashes on weekends and at night involve alcohol. 19 There is evidence that the majority of medical marijuana patients are male. In fact, according to state registry data, 75 percent of patients in Arizona, and 68 percent of patients in Colorado, are male. There is also evidence that many patients are below the age of 40. Forty-eight percent of registered patients in Montana, and 42 percent of registered patients in Arizona, are between the ages of 18 and 40; the average age of registered patients in Colorado is 41.
20
A standard difference-in-differences (DD) regression is used to evaluate the impact of MMLs on traffic fatalities. This approach allows us to exploit the panel nature of our data by To the extent that registered patients below the age of 40 are more likely to use medical marijuana recreationally, one might expect heterogeneous effects by age.
The empirical model
12 estimating a model that includes both state and year fixed effects. Specifically, the baseline estimating equation is:
where s indexes states and t indexes years.
21
The vector X st is composed of the controls described in (Ledolter and Chan 1996; Farmer et al. 1999; Greenstone 2002; Dee and Sela 2003) , BAC laws (Dee 2001; Eisenberg 2003) , and Zero Tolerance Laws (Carpenter 2004; Liang and Huang 2008; Grant 2010) . The relationship between beer taxes and traffic fatalities has also received attention from economists (Chaloupka et al. 1991; Ruhm 1996; Dee 1999; Young and Likens 2000) .
The variable MML st indicates whether a MML was in effect in state s and year t, and β 1 , the coefficient of interest, represents the marginal effect of legalizing medical marijuana. In alternative specifications we replace Fatalities Total st with the remaining dependent variables listed in Table 5. 22 21 Dee (2001) used a similar specification to examine the relationship between 0.08 BAC laws and traffic fatalities. See also Dee and Sela (2003) and Lovenheim and Steefel (2011) .
22 Information on graduated driver licensing laws and seatbelt requirements is available from Dee et al. (2005) , Cohen and Einav (2003) , and the Insurance Institute for Highway Safety (iihs.org). The FARS accident files were used to construct the variable Speed 70.
In addition to these polices, we include an indicator for marijuana decriminalization, the state unemployment rate, and real per capita income. 23 Finally, following
Eisenberg (2003), we control for the vehicle miles driven per licensed driver in the state.
24
The final specification of Table 7 includes state-specific linear time trends. Table 7 presents OLS estimates of the relationship between MMLs and traffic fatalities.
The estimated relationship between MMLs and traffic fatalities
The regressions are weighted by the population of licensed drivers in state s and year t, and the standard errors are corrected for clustering at the state-level (Bertrand et al. 2004 ).
In the first column, we present the most basic specification. Without controls and fixed effects, the legalization of medical marijuana is associated with a 22 percent decrease in the traffic fatality rate (e -0.248 -1 = -0.220). When state and year fixed effects are included, legalization is associated with a 9.7 percent decrease in the fatality rate. Adding the state-level controls decreases the magnitude of the estimated relationship between MMLs and traffic fatalities still further. Legalization is associated with a 7.9 percent decrease in the traffic fatality rate.
25 23 Data on decriminalization laws are from Model (1993) and Scott (2010) . The possession and use of marijuana is not legal in decriminalized states, but expected penalties and fines are lower than those in states without such legislation. For our sample period, however, the decriminalization variable only captures one policy change; Nevada decriminalized the use of marijuana in 2001. The majority of decriminalization laws were passed prior to 1990. The unemployment and income data are from the Bureau of Labor Statistics and the Bureau of Economic Analysis, respectively.
24 Due to missing data, the number of miles driven in Arizona was imputed for 2009. 25 In other words, it includes an interaction between the state dummies and a variable equal to 1 in 1990, 2 in 1991, 3 in 1993, and so forth. State-specific linear time trends are included in all subsequent specifications. (Table 8 ). The estimate of β 1 is negative when fatalities not involving alcohol are considered, but it is relatively small and statistically indistinguishable from zero. In contrast, the legalization of medical marijuana is associated with an almost 12 percent decrease in any-BAC fatal crashes per 100,000 licensed drivers, and an almost 14 percent decrease in high-BAC fatal crashes per 100,000 licensed drivers. Table 9 shows pre-and post-legalization trends in fatal crashes involving alcohol. later, more than 7,000 patients were registered; and six years later, 27,292 patients were registered.
26 Table 10 provides additional evidence that MMLs decrease traffic fatalities by reducing alcohol consumption. The first two columns of Table 10 show the relationship between MMLs and traffic fatalities occurring on weekdays as compared to the weekend, when the consumption of alcohol rises (Haines et al. 2003) . Legalization is associated with a 7.8 percent decrease in the weekday traffic fatality rate; in comparison, it is associated with a 9.5 percent decrease in the weekend traffic fatality rate. The former estimate is not significant at conventional levels, while the latter is significant at the 0.05 level.
27
The last two columns of Table 10 show the relationship between MMLs and traffic fatalities occurring during the day as compared to at night, when fatal crashes are more likely to involve alcohol (Dee 1999) . Legalization is associated with a 6.8 percent decrease in the daytime traffic fatality rate; in comparison, it is associated with a 10.1 percent decrease in the nighttime traffic fatality rate. The former estimate is not significant at conventional levels, but the latter is significant at the 0.10 level. 30 The hypothesis that these estimates are equal can be rejected at the 0.05 level.
28
MEDICAL MARIJUNA LAWS, ALCOHOL CONSUMPTION AND SALES
Number of Drinks per Month and Binge Drinking
Administered by state health departments in collaboration with the Centers for Disease Control, the Behavioral Risk Factor Surveillance System (BRFSS) is designed to measure "behavioral risk factors" for the adult population (18 years of age or older Specifically, the BRFSS asks, "Considering all types of alcoholic beverages, how many times during the past 30 days did you have X or more drinks on an occasion?", where X is five for male respondents and 4 for female respondents.
32 The vector X st includes the controls listed in Table 6 with the following exceptions: Miles driven, GDL, Primary seatbelt, Secondary seatbelt, and Speed 70. We also control for the relevant age-or sex-specific population.
The bottom panel presents estimates of (2) drinkers. Although the estimates of π 1 are negative for every age group, the estimated relationship between MMLs and drinking is strongest among 20-through 29-year-olds.
Alcohol Sales
Data from the alcohol industry is collected by the Beer Institute and published annually in (Table 14) . The legalization of medical marijuana is associated with a 5.3 percent reduction in beer sales, the most popular beverage among 18-through 29-year-olds during the period under study (Jones 2008 of "making marijuana legally available for doctors to prescribe in order to reduce pain and suffering" (Mendes 2010 ).
Although popular, medical marijuana laws have received minimal scrutiny from researchers. In fact, next to nothing is known about their impact on outcomes of interest to policymakers, social scientists, advocates, and opponents.
The current study draws on data from a variety of sources to explore the effects of legalizing medical marijuana. Using data from the National Survey on Drug Use and Health (NSDUH), we find that the use of marijuana by adults in Montana and Rhode Island increased after medical marijuana was legalized. Although opponents of legalization argue that it encourages recreational use among teenagers (Brady et al. 2011 ; O'Keefe and Earleywine 2011),
we find no evidence that the use of marijuana by minors increased.
Using data from the Fatality Analysis Reporting System (FARS) for the period 1990-2009, we find that traffic fatalities fall by nearly 9 percent after the legalization of medical marijuana. This effect is comparable in magnitude to those found by economists using the FARS data to examine other policies. For instance, Dee (1999) found that increasing the minimum legal drinking age to 21 reduces fatalities by approximately 9 percent; Carpenter and Stehr (2008) found that mandatory seatbelt laws decrease traffic fatalities among 14-through 18-yearolds by approximately 8 percent.
Why does legalizing medical marijuana reduce traffic fatalities? Alcohol consumption appears to play a key role. The legalization of medical marijuana is associated with a 6.4 percent decrease in fatal crashes that did not involve alcohol, but this estimate is not statistically significant at conventional levels. In comparison, the legalization of medical marijuana is associated with an almost 12 percent decrease in any-BAC fatal crashes per 100,000 licensed 20 drivers, and an almost 14 percent decrease in high-BAC fatal crashes per 100,000 licensed drivers.
The negative relationship between legalization of medical marijuana and traffic fatalities involving alcohol is consistent with the hypothesis that marijuana and alcohol are substitutes. In order to explore this hypothesis further, we examine the relationship between medical marijuana laws and alcohol consumption using data from the Behavioral Risk Factor Surveillance System and The Brewer's Almanac. We find that the legalization of medical marijuana is associated with decreased alcohol consumption, especially by 20-through 29-year-olds. In addition, we find that legalization is associated with decreased beer sales, the most popular alcoholic beverage among young adults (Jones 2008) .
Evidence from simulator and driving course studies provides a simple explanation for why substituting marijuana for alcohol may lead to fewer traffic fatalities. These studies show that alcohol consumption leads to an increased risk of collision (Kelly et al. 2004; Sewell et al. 2009 ). Even at low doses, drivers under the influence of alcohol tend to underestimate the degree to which they are impaired (MacDonald et al. 2008; Marczinski et al. 2008; Robbe and O'Hanlon 1993; Sewell et al. 2009 ), drive at faster speeds, and take more risks (Burian et al. 2002; Ronen et al. 2008; Sewell et al. 2009 ). In contrast, simulator and driving course studies provide only limited evidence that driving under the influence of marijuana leads to an increased risk of collision, perhaps as a result of compensatory driver behavior (Kelly et al. 2004; Sewell et al. 2009 ).
However, because other mechanisms cannot be ruled out, the negative relationship between medical marijuana laws and alcohol-related traffic fatalities does not necessarily imply that driving under the influence of marijuana is safer than driving under the influence of alcohol.
21
For instance it is possible that legalizing medical marijuana reduces traffic fatalities though its effect on substance use in public. Alcohol is often consumed in restaurants and bars, while many states prohibit the use of medical marijuana in public. 35 Even where it is not explicitly prohibited, anecdotal evidence suggests that the public use of medical marijuana can be controversial. 36 If marijuana consumption typically takes place at home, then designating a driver for the trip back from a restaurant or bar becomes unnecessary, and legalization could reduce traffic fatalities even if driving under the influence of marijuana is every bit as dangerous as driving under the influence of alcohol.
Finally, an important caveat deserves mention. Our classification of states into those that allow the use of medical marijuana and those that prohibit its use does not capture potentially important factors such as whether formal registration with the state is compulsory or voluntary, what types of ailments are covered, and whether an official dispensary system is in place. While measuring these differences and their impact is beyond the scope of this study, future research could explore the nuances of these laws. Notes: Each column represents the results from a separate regression. The dependent variable is equal to the natural log of fatalities per 100,000 population; the covariates are listed in Table 6 . Regressions are weighted using the relevant state-by-age populations. Standard errors, corrected for clustering at the state level, are in parentheses. Notes: Each column represents the results from a separate regression. The dependent variable is equal to the natural log of fatalities per 100,000 population; the covariates are listed in Table 6 . Regressions are weighted using the relevant state-by-sex populations. Standard errors, corrected for clustering at the state level, are in parentheses. (1990-2009) (1994-2009) (1994-2009) 
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